![](/img/cover-not-exists.png)
PCN18 OUTCOMES RESEARCH OF BORTEZOMIB INDICATED FOR MULTIPLE MYELOMA IN THE CONTEXT OF THE DUTCH REIMBURSEMENT POLICY FOR EXPENSIVE MEDICINES: THREATS TO THE INTERNAL VALIDITY OF THE INCREMENTAL EFFECTIVENESS ESTIMATE
J Gaultney, M Franken, CWM van Gils, P Huijgens, WK Redekop, CA Uyl-de GrootVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74270-4
File:
PDF, 71 KB
english, 2009